Featured Research

from universities, journals, and other organizations

Smear Campaign: Faster Detection Of Multidrug-resistant TB For Public Health

Date:
April 4, 2008
Source:
American Thoracic Society
Summary:
There is a new tool in the arsenal to fight multidrug-resistant tuberculosis: a rapid diagnostic test that can function in high-burden settings such as public health clinics. MDR-TB is increasingly on the rise, and spreads most rapidly through vulnerable communities that are already riven by HIV and poverty. One of the biggest barriers to appropriate treatment is the lengthy diagnostic process of conventional techniques that is not well-suited to public health settings serving vulnerable populations.

There is a new tool in the arsenal to fight multidrug-resistant tuberculosis (MDR-TB): a rapid diagnostic test that can function in high-burden settings such as public health clinics. MDR-TB is increasingly on the rise, and spreads most rapidly through vulnerable communities that are already riven by HIV and poverty. One of the biggest barriers to appropriate treatment is the lengthy diagnostic process of conventional techniques that is not well-suited to public health settings serving vulnerable populations.

"With continued delay of testing results, and thus, treatment, the patient will likely transmit the infection to those persons they come in close contact with," said Richard O'Brien, M.D., senior investigator from the Foundation for Innovative New Diagnostics, a nonprofit funded in part by USAID and the Bill & Melinda Gates Foundation, which sponsored the study. "TB is already the leading cause of death among AIDS patients worldwide. This association is particularly lethal when drug-resistant TB is being transmitted. MDR-TB, with resistance to the most important anti-TB drugs, isoniazid and rifampicin, is even more lethal."

The study is reported in first issue for April of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. Dr. O'Brien and his colleagues found that using a molecular assay test, as opposed to conventional culture techniques, may revolutionize the diagnosis and reporting of MDR-TB in these high-infection areas by delivering the critical results more quickly, and perhaps even more accurately--thus enabling proper treatment to begin promptly.

The study took place in a national health laboratory in Cape Town, South Africa, which serves over 4.2 million people and processes about 400,000 specimens annually. The testing was performed on residual portions of specimens originally collected for other purposes. They were able to obtain interpretable results within 1-2 days in 97 percent of smear-positive samples, and had a better than 98 percent specificity and sensitivity rate for multidrug resistance.

"The advantage of this test, based on its performance in the lab in South Africa are its equivalent or perhaps increased accuracy compared to standard methods and an increase in the number of interpretable results, as standard techniques are subject to contamination," said Dr. O'Brien. "Additionally, it only takes 1-2 days, as opposed to the mean turnaround time of 42 days with conventional cultures."

The two to three months that conventional techniques can take to determine drug resistance can be fatal to an HIV-infected patient. Complicating the picture is the looming threat of MDR-TB becoming XDR-TB--extensively drug resistant. "If patients receive inappropriate treatment because of the lack of proper screening, the risk of developing increasingly resistant and consequently, virtually untreatable strains of TB in these already vulnerable populations is much higher," said Dr. O'Brien.

While this diagnostic method had been in existence, until now it had not been tested under real-world conditions in a high-volume public health laboratory in a low-income, disease-endemic country. "We evaluated this test in response to the call for implementation of rapid tests by the World Health Organization and its partners," said Dr. O'Brien.

"This test is now being evaluated in program conditions in a number of countries where MDR-TB is epidemic," said Dr. O'Brien. "We expect that more widespread use of this test will be a great improvement in our ability to address this serious problem that threatens the global control of tuberculosis."

Such an improvement in diagnosis in public health settings could take clinicians treating TB in high-burden areas out of "the dark," said Max Salfinger, M.D. and David Ashkin, A.G. in an editorial in the same issue of the journal.


Story Source:

The above story is based on materials provided by American Thoracic Society. Note: Materials may be edited for content and length.


Cite This Page:

American Thoracic Society. "Smear Campaign: Faster Detection Of Multidrug-resistant TB For Public Health." ScienceDaily. ScienceDaily, 4 April 2008. <www.sciencedaily.com/releases/2008/04/080401081917.htm>.
American Thoracic Society. (2008, April 4). Smear Campaign: Faster Detection Of Multidrug-resistant TB For Public Health. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2008/04/080401081917.htm
American Thoracic Society. "Smear Campaign: Faster Detection Of Multidrug-resistant TB For Public Health." ScienceDaily. www.sciencedaily.com/releases/2008/04/080401081917.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins